Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Overexpression of Wnt ligands and treatment of lytic bone diseases

Overexpression of Wnt ligands and treatment of lytic bone diseases

US Patent 8501702 · Granted Aug 6, 2013

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Use of gene expression profiling to predict survival in cancer patient2020
Diagnosis, prognosis and identification of potential therapeutic targets of mult2020
Diagnosis, prognosis and identification of potential therapeutic targets of mult2017
Use of gene expression profiling to predict survival in cancer patient2017
Diagnosis, prognosis and identification of potential therapeutic targets of mult2017
Compositions, kits, and methods for identification, assessment, prevention, and 2016
Treatment of bone-related cancers using placental stem cells2015
Methods of increasing bone mass in a subject comprising inhibiting DKK12015
Methods of increasing bone mass in a subject comprising inhibiting DKK12015
Diagnosis, prognosis and identification of potential therapeutic targets of mult2015
Use of gene expression profiling to predict survival in cancer patient2014
Methods and compositions for treatment of bone defects with placental cell popul2014